Christophe E Iselin
Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment.
Menges D, Piatti M, Omlin A, Cathomas R, Benamran D, Fischer S, Iselin C, Kueng M, Lorch A, Prause L, Rothermundt C, O'Meara Stern A, Zihler D, Lippuner M, Braun J, Cerny T, Puhan M. Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment. Eur Urol Open Sci 2023; 51:26-38.
Mar 22, 2023Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment.
Mar 22, 2023Eur Urol Open Sci 2023; 51:26-38
Menges Dominik, Piatti Michela C, Omlin Aurelius, Cathomas Richard, Benamran Daniel, Fischer Stefanie, Iselin Christophe E, Kueng Marc, Lorch Anja, Prause Lukas, Rothermundt Christian, O'Meara Stern Alix, Zihler Deborah, Lippuner Max, Braun Julia, Cerny Thomas, Puhan Milo Alan
Sacral neuromodulation for refractory lower urinary tract dysfunction: results of a nationwide registry in Switzerland
Kessler T, Zrehen S, Schurch B, Schmid D, Roche B, Iselin C, Bersch U, Al-Khodairy A, Engeler D, Meyer S, Buchser E, Burkhard F. Sacral neuromodulation for refractory lower urinary tract dysfunction: results of a nationwide registry in Switzerland. European urology 2007; 51:1357-63.
May 1, 2007Sacral neuromodulation for refractory lower urinary tract dysfunction: results of a nationwide registry in Switzerland
May 1, 2007European urology 2007; 51:1357-63
Kessler Thomas M, Zrehen Stephane, Schurch Brigitte, Schmid Daniel M, Roche Bruno, Iselin Christophe E, Bersch Ulf, Al-Khodairy Abdul-Wahab, Engeler Daniel, Meyer Sylvain, Buchser Eric, Burkhard Fiona C